0000899243-22-036936.txt : 20221123
0000899243-22-036936.hdr.sgml : 20221123
20221123163111
ACCESSION NUMBER: 0000899243-22-036936
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221122
FILED AS OF DATE: 20221123
DATE AS OF CHANGE: 20221123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Topper David Joseph
CENTRAL INDEX KEY: 0001740378
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39765
FILM NUMBER: 221416734
MAIL ADDRESS:
STREET 1: C/O GENERAL ATLANTIC SERVICE COMPANY, LP
STREET 2: 55 EAST 52ND STREET, 32ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10055
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frazier Lifesciences Acquisition Corp
CENTRAL INDEX KEY: 0001828326
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO UNION SQUARE, 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: 617-570-8364
MAIL ADDRESS:
STREET 1: TWO UNION SQUARE, 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-22
1
0001828326
Frazier Lifesciences Acquisition Corp
FLAC
0001740378
Topper David Joseph
C/O FRAZIER LIFESCIENCES ACQUISITION
TWO UNION SQUARE, 601 UNION ST. STE 3200
SEATTLE
WA
98101
1
1
0
0
Chief Financial Officer
Class B Ordinary Shares
2022-11-22
4
M
0
30000
D
Class A Ordinary Shares
30000
0
D
Pursuant to the terms outlined in the Business Combination Agreement, dated July 25, 2022, by and among NewAmsterdam Pharma Holding B.V., Frazier Lifesciences Acquisition Corporation, NewAmsterdam Pharma Investment Corporation, and NewAmsterdam Pharma Company B.V., these shares were automatically converted into Class A ordinary shares of NewAmsterdam Pharma Company N.V. (Nasdaq symbol "NAMS"). The Business Combination closed on November 22, 2022.
/s/ David Topper
2022-11-23